Jasper Therapeutics is trading 5.19% down now at $0.66, with no clear company-specific catalyst identified.
- No company-specific announcement, earnings update, regulatory action, or analyst revision dated September 11, 2026, was identified.
- The latest company release, dated September 9, concerned participation in the H.C. Wainwright conference.
- Broader markets were rising, so the decline does not appear explained by overall market direction.